Caffeine and Bones: If Less Is Good, More May Not Be Better

por Antonioli, Luca, Haskó, György
Publicado en J Caffeine Adenosine Res (2019)

Adenosine Metabolism, Immunity and Joint Health

por Hasko, George, Antonioli, Luca, Cronstein, Bruce N.
Publicado en Biochem Pharmacol (2018)

Myeloid cells in the tumor microenvironment: Role of adenosine

por Morello, Silvana, Pinto, Aldo, Blandizzi, Corrado, Antonioli, Luca
Publicado en Oncoimmunology (2015)

The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases

por Antonioli, Luca, Blandizzi, Corrado, Pacher, Pál, Haskó, György
Publicado en Pharmacol Rev (2019)

NKG2A and COVID-19: another brick in the wall

por Antonioli, Luca, Fornai, Matteo, Pellegrini, Carolina, Blandizzi, Corrado
Publicado en Cell Mol Immunol (2020)

CD39 and CD73 in immunity and inflammation

por Antonioli, Luca, Pacher, Pál, Vizi, E. Sylvester, Haskó, György
Publicado 2013

A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric ‘purinome’ concept

por Antonioli, Luca, Fornai, Matteo, Colucci, Rocchina, Tuccori, Marco, Blandizzi, Corrado
Publicado 2011

Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment

por Antonioli, Luca, Blandizzi, Corrado, Malavasi, Fabio, Ferrari, Davide, Haskó, György
Publicado en Oncoimmunology (2016)

Quorum sensing in the immune system

por Antonioli, Luca, Blandizzi, Corrado, Pacher, Pál, Guilliams, Martin, Haskó, György
Publicado en Nat Rev Immunol (2018)

Rethinking communication in the immune system: the quorum sensing concept

por Antonioli, Luca, Blandizzi, Corrado, Pacher, Pál, Guilliams, Martin, Haskó, György
Publicado en Trends Immunol (2019)

Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases

por Pellegrini, Carolina, Fornai, Matteo, Antonioli, Luca, Blandizzi, Corrado, Calderone, Vincenzo
Publicado en Int J Mol Sci (2019)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives

por Antonioli, Luca, Fornai, Matteo, Romano, Barbara, Pellegrini, Carolina, Blandizzi, Corrado
Publicado en Front Pharmacol (2020)

Anti-CD73 in cancer immunotherapy: awakening new opportunities

por Antonioli, Luca, Yegutkin, Gennady G., Pacher, Pál, Blandizzi, Corrado, Haskó, György
Publicado en Trends Cancer (2016)

Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation

por Pellegrini, Carolina, Antonioli, Luca, Lopez-Castejon, Gloria, Blandizzi, Corrado, Fornai, Matteo
Publicado en Front Immunol (2017)

Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?

por D’Antongiovanni, Vanessa, Fornai, Matteo, Pellegrini, Carolina, Blandizzi, Corrado, Antonioli, Luca
Publicado en Front Pharmacol (2021)

Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche

por Chillemi, Antonella, Quarona, Valeria, Antonioli, Luca, Ferrari, Davide, Horenstein, Alberto L., Malavasi, Fabio
Publicado en Front Immunol (2017)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases

por Dal Ben, Diego, Antonioli, Luca, Lambertucci, Catia, Fornai, Matteo, Blandizzi, Corrado, Volpini, Rosaria
Publicado en Front Pharmacol (2018)

What's New in Emergencies, Trauma, and Shock? Using Abdominal Computed Tomography in Geriatric Patients on Warfarin

por Bogdanovski, Dorian A., Hakakian, Daniel, DiFazio, Louis T., Antonioli, Luca, Nemeth, Zoltan H.
Publicado en J Emerg Trauma Shock (2018)

P2X4 receptors, immunity, and sepsis

por Antonioli, Luca, Blandizzi, Corrado, Fornai, Matteo, Pacher, Pál, Lee, H. Thomas, Haskó, György
Publicado en Curr Opin Pharmacol (2019)

Inflammatory Bowel Diseases: It's Time for the Adenosine System

por Antonioli, Luca, Fornai, Matteo, Pellegrini, Carolina, Bertani, Lorenzo, Nemeth, Zoltan H., Blandizzi, Corrado
Publicado en Front Immunol (2020)